SynCardia Systems

$80$125

SynCardia Systems, Inc. provides health care products and services. The Company manufactures artificial human hearts as a bridge to human heart transplant for people dying from end-stage biventricular failure. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart (TAH) is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® Portable Driver, which powers the SynCardia TAH and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Report ID:

UMHE21032

Published:

feb-2022

Pages:

11

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21032 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1. Key Facts of the Company
2. Company Mission
3. Company Value
4. Growth Strategy
5. Key Products & Services Offered
6. Infographic
7. Competitors
8. Executive Team
9. SWOT Analysis”

Companies Mentioned

“Abbott Laboratories
Abiomed
Teleflex Incorporated
Fresenius Medical Care AG
Getinge”